Background <p>Neonatal ichthyosis sclerosing cholangitis (NISCH) syndrome is a rare autosomal recessive syndrome due to mutations in the claudin-1 gene (CLDN1). Defective expression of claudin-1 protein manifests with involvement of the liver and skin. Phenotypic expression of the disease varies from cholangitis resolving on supportive management to severe liver damage requiring liver transplantation.</p> Case presentation <p>We hereby discuss an Indian infant presenting with neonatal cholestasis and ichthyosis, carrying a novel nonsense mutation in exon 3 of the CLDN1 gene (p.Pro154LeufsTer2). We also report a striking association between NISCH syndrome and hyperferritinemia; the pathophysiology for the same is yet to be elucidated. The patient’s clinical condition improved after supportive management, including vitamin supplementation, ursodeoxycholic acid, and emollients.</p> Conclusion <p>Awareness, early diagnosis, genotype-phenotype correlation, and timely and appropriate management are key to the prognostication of the patient.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Genetic insights into neonatal ichthyosis sclerosing cholangitis (NISCH) syndrome

  • Pooja Soni,
  • Ranu Tripathi,
  • Kapil Dev Rabha,
  • Bhavna Dhingra

摘要

Background

Neonatal ichthyosis sclerosing cholangitis (NISCH) syndrome is a rare autosomal recessive syndrome due to mutations in the claudin-1 gene (CLDN1). Defective expression of claudin-1 protein manifests with involvement of the liver and skin. Phenotypic expression of the disease varies from cholangitis resolving on supportive management to severe liver damage requiring liver transplantation.

Case presentation

We hereby discuss an Indian infant presenting with neonatal cholestasis and ichthyosis, carrying a novel nonsense mutation in exon 3 of the CLDN1 gene (p.Pro154LeufsTer2). We also report a striking association between NISCH syndrome and hyperferritinemia; the pathophysiology for the same is yet to be elucidated. The patient’s clinical condition improved after supportive management, including vitamin supplementation, ursodeoxycholic acid, and emollients.

Conclusion

Awareness, early diagnosis, genotype-phenotype correlation, and timely and appropriate management are key to the prognostication of the patient.